T

Tandem Health

AI medical documentation and decision-support platform

Account Executive

Full-Time
No salary listed
Mid
London, UK
In PersonThe role includes a working day in the London office and periodic team meetings, social events, and offsites in Sweden.

About the job

Requirements
  • Demonstrable experience in business-to-business sales and new business, ideally in software as a service, digital health, or technology.
  • A track record of achieving sales targets and progressing opportunities through a sales funnel.
  • Experience with outbound prospecting and managing sales opportunities through to close.
  • Strong communication, presentation, and consultative selling skills.
  • Interest in and ideally some understanding of the United Kingdom private healthcare market.
  • Commercial mindset, drive, curiosity, and comfort working in a fast-paced environment.
  • Strong ownership and willingness to learn and develop as a salesperson.
  • Genuine enthusiasm for technology and artificial intelligence.
Responsibilities
  • Own and deliver against a personal sales target across United Kingdom private healthcare.
  • Build pipeline through outbound prospecting, inbound leads, referrals, and events.
  • Manage opportunities through the full sales cycle, from first contact to close.
  • Build relationships with healthcare professionals and decision-makers across private healthcare.
  • Run discovery calls, product demonstrations, and commercial conversations.
  • Work closely with Delivery and Medical Operations to ensure a smooth customer handover.
  • Collaborate with Marketing, Product, and Leadership to improve the sales approach and market positioning.
  • Represent Tandem at relevant healthcare events and conferences.
  • Maintain strong customer relationship management, pipeline, and forecasting discipline.
Desired Qualifications
  • Experience selling software as a service, digital health, or artificial intelligence.
  • Experience selling into United Kingdom private healthcare, including providers, practices, consultants, or insurers.
  • Experience with clinical or healthcare workflows.
  • Experience in a startup or scale-up environment.

About the company

Tandem Health builds an AI medical assistant and clinic co-pilot that reduces clinician documentation burden by turning consultations into medical notes, handling coding, and offering decision support. The platform is CE-marked, encrypts data, and processes information under European regulatory standards. It connects with more than 130 electronic medical record systems across 14 markets and is used by thousands of care organizations. Tandem’s roadmap aims to evolve from AI documentation tools toward an AI-native clinic operating system that manages patient flow and agentic clinical tasks.

Company Size

201-500

Company Stage

Series B

Total Funding

$159.5M

Headquarters

Stockholms kommun, Sweden

Founded

2023

Get referred to Tandem Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • EQT's Scaleup Europe Fund led Tandem's $100 million Series B on September 14, 2026.
  • March 2026 NHS England coverage gave Tandem access to 10,000 clinicians across trusts.
  • June and September 2026 partnerships with Philips and Aurora teleQ widened distribution and workflow reach.

What critics are saying

  • Heidi and Microsoft Dragon Copilot attack Tandem's NHS and European procurement pipelines in 2026.
  • Sweden's regulator already forced Tandem from self-declared Class I into Class IIa scrutiny.
  • Any safety recall or MDR adverse-event finding threatens Tandem's entire regulated platform.

What makes Tandem Health unique

  • September 2026, Tandem became Europe's only clinical AI platform with three Class IIa devices.
  • Tandem serves 10,000+ care organisations across 14 countries and integrates deeply with EPRs.
  • Ask Tandem unifies scribe, coding, and live clinical decision support in one workflow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

↓ -3%

1 year growth

↑ 3%

2 year growth

↑ 14%
Epium Ltd
Sep 23rd, 2026
Tandem Health raises $100 million for European healthcare AI.

Tandem Health raises $100 million for European healthcare AI. Stockholm-based Tandem Health has raised $100 million in Series B funding led by the Scaleup Europe Fund, managed by EQT, in the fund's first healthcare AI investment. Existing backers Kinnevik, Northzone, Amino Collective, and Visionaries also joined, bringing total funding to $160 million. Tandem develops an AI medical assistant for clinicians that prepares patient summaries, supports clinical decisions, and automates documentation and coding. Its AI Scribe, Coding Assistant, and Clinical Decision Support products are each independently certified as Class IIa medical devices under the EU Medical Device Regulation. The company says clinicians using Tandem report a 29% reduction in admin time, a 30% improvement in job satisfaction, and a 30% reduction in administrative stress. Since being founded three years ago, Tandem has opened offices in 14 European markets and has been brought to over 10,000 care organizations, including Ramsay Santé, Humanitas, and the NHS. New funding will support broader adoption across Europe, expansion of its clinician-led team of 75+ inhouse clinicians, and development of an AI-native Clinic Operating System designed to manage patient flows and handle more clinical tasks.

FundingTrip
Sep 23rd, 2026
Tandem Health: scaling AI to transform clinical workflows across Europe.

Tandem Health: scaling AI to transform clinical workflows across Europe. Stockholm-based Tandem Health is developing AI software designed to reduce the administrative workload faced by healthcare professionals. Its best-known product is an AI medical assistant that listens to consultations and helps generate structured clinical notes. The goal is simple: reduce the amount of time clinicians spend documenting appointments so they can dedicate more attention to patients. The company is now expanding this concept beyond clinical documentation. Its longer-term ambition is to develop an AI-native operating system for clinical workflows, covering additional activities such as patient flows, clinical decision support, documentation and coding. By September 2026, Tandem said its technology was being used by around 10,000 care organisations across 14 European countries. This post covers: * The September 2026 Series B * From medical notes to an AI-native healthcare platform * Tandem's funding journey * What the funding journey shows * Fundingtrip: insights about funding The September 2026 Series B. September 2026 marks another major stage in Tandem Health's growth. The Swedish company is finalising a $100 million Series B led by the Scaleup Europe Fund, managed by EQT. The round represents the fund's first investment in AI healthcare. Existing investors including Kinnevik, Northzone, Amino Collective and Visionaries Club are also participating. The new capital is intended to accelerate Tandem's expansion among European healthcare providers and support the company's evolution from an AI medical assistant into a broader clinical operating system. The timing is significant. Tandem is raising at a point when its technology has already achieved substantial adoption, meaning the new capital is being deployed primarily for scaling rather than initial product validation. From medical notes to an AI-native healthcare platform. Tandem's product addresses one of healthcare's persistent problems: the amount of administrative work required from clinicians. Its AI assistant can prepare patient summaries, generate documentation during or after consultations and support administrative workflows such as coding. Tandem says clinicians using its products report a reduction in time spent on administrative tasks. The company is also building integrations across European healthcare systems. This is particularly important because healthcare is highly fragmented across countries, with different languages, regulations, workflows and information systems. Rather than treating this complexity only as a barrier, Tandem's European focus has become part of its positioning. The company aims to develop AI specifically for European healthcare environments. Tandem's funding journey. Tandem's earlier funding rounds established the foundations for its current expansion. The company raised an approximately €8.9 million seed round in June 2024, with investors including Northzone, Amino Collective, Google DeepMind, OpenAI and the founder of Capio Sverige. In June 2025, Tandem announced a $50 million Series A, led by Kinnevik with participation from Northzone, Amino Collective and Visionaries Club. Kinnevik reported that it invested €30 million in the €40 million funding round. The Series A provided the resources for European expansion and further product development. The September 2026 Series B now represents a substantial step up in scale, with the company moving from expansion to building a broader AI platform for healthcare. What the funding journey shows. Tandem's journey highlights the importance of proving real-world adoption before pursuing major scale-up capital. The company did not raise its largest round simply because healthcare AI was a promising market. Its financing followed evidence that clinicians and healthcare organisations were actually using the product. The progression from a focused clinical documentation product to a wider healthcare platform also demonstrates how funding can support a strategic expansion of the original business model. For founders, the lesson is to connect fundraising milestones with measurable business milestones. Investors need to see not only what a company could become, but evidence that its technology is already solving a meaningful problem. Fundingtrip: insights about funding. Tandem Health's funding journey shows why founders need to understand how different rounds relate to product maturity, traction and expansion plans. Fundingtrip helps entrepreneurs navigate these stages, identify suitable funding opportunities and prepare a stronger financing strategy. Entrepreneurs who want to build these skills can discover the Fundingtrip courses. Sara Gavidia Content Creator Communications Manager & Content creator LinkedIn [email protected] Hello! I'm Sara Post reviewed by David Arias, funding expert.

MKFM
Sep 13th, 2026
€5bn EU fund leads $100M round for AI medical assistant Tandem Health

Swedish-based Tandem Health has secured $100 million in Series B funding led by the Scaleup Europe Fund, managed by EQT. This marks the €5 billion fund's first investment in AI healthcare. Tandem Health develops an AI medical assistant that reduces administrative burdens for clinicians by generating notes during patient consultations. The company reports users experience a 29% reduction in time spent on administrative tasks. The round includes participation from T.Capital and Norrsken Ventures, with existing investors Kinnevik, Northzone, Amino Collective and Visionaries also backing the raise. This follows a $50 million Series A round last year. Tandem Health serves 10,000 care organisations across 14 European countries. In the UK, it partners with Accurx, providing access to hundreds of thousands of NHS practitioners. The funding will accelerate growth and expand the platform into an AI-native clinic operating system.

Breakit
Jul 14th, 2026
Swedish healthtech Tandem Health on track after $56.5M round from Kinnevik and Northzone

Swedish healthtech startup Tandem Health has raised over half a billion Swedish kronor in venture capital from investors including Kinnevik and Northzone. The company develops AI-based journal tools for healthcare providers. Chief executive and co-founder Lukas Saari told Breakit the company is "building for the long term" and following its plan. Previously, details about the startup's sales performance had not been publicly disclosed. The funding round, which closed last year, represents significant backing from prominent Scandinavian investors. Tandem Health's technology aims to streamline documentation processes in healthcare settings through artificial intelligence.

Streets Heaver
Jul 2nd, 2026
Streets Heaver partners with Tandem Health to bring enterprise-grade Ambient AI documentation into compucare(r) Clinician Pro.

Streets Heaver partners with Tandem Health to bring enterprise-grade Ambient AI documentation into compucare(r) Clinician Pro. By Holly Johnson, Marketing Executive Streets Heaver Healthcare Computing is pleased to announce a strategic partnership with Tandem Health, bringing enterprise-grade Ambient AI documentation directly into Compucare Clinician Pro. The integration will provide healthcare organisations with a fully embedded experience, enabling clinicians to capture consultations, generate structured clinical documentation and correspondence, and return approved outputs directly into the patient record, all without leaving Compucare. This partnership marks another significant milestone in Streets Heaver's AI strategy, complementing the company's native AI platform, NIVA, while reinforcing its commitment to delivering safe, governed and practical AI solutions for private healthcare providers and NHS Private Patient Units. As one of the UK's most widely adopted private healthcare management platforms, Compucare continues to evolve around the needs of clinicians, operational teams and healthcare leaders. This latest development reflects a clear focus on reducing administrative burden, improving workflow efficiency and supporting better patient care through intelligent technology. A native experience built for clinical workflows. Unlike standalone AI tools that operate separately from core clinical systems, the Tandem integration has been designed as a seamless part of the Compucare experience. Clinicians will be able to launch Tandem directly from within Compucare Clinician Pro. Patient and appointment context will flow through automatically, consultations will be captured and structured in real time, and approved documentation will return directly into the patient's record. The result is a more streamlined clinical workflow that reduces documentation burden while maintaining clinician oversight and control. Announcing the partnership, Benedict Heaver, CEO of Streets Heaver Healthcare Computing, said: "For its customers, this offers a native, embedded experience where clinicians launch Tandem directly from inside Compucare, consultations are captured and structured automatically, and approved output flows straight back into your patient record. Streets Heaver has spent months evaluating the Ambient AI landscape carefully. What set Tandem apart was not just the product, it was the alignment. They are MDR Class IIa certified for their Scribe & Coding Assistant, externally audited, and built for the enterprise private healthcare environment Streets Heaver serve. This will sit alongside its native AI, NIVA, which is already baked into its products and extends its AI vision, in a safe and transparent way. To its existing customers, Streets Heaver'll be in touch over the coming weeks to talk through what this means for you. To the wider market, this is building on its existing investments in AI across its platform in a way that's safe, governed and useful." Why Tandem Health? Founded in Stockholm, Tandem Health has emerged as one of Europe's leading Ambient AI healthcare companies, helping clinicians reduce documentation time through AI-powered clinical note generation and workflow support. The company's focus on clinical governance, compliance and healthcare-specific design closely aligns with Streets Heaver's approach to healthcare technology. Dr Katie Baker, GTM Director, UK & Ireland at Tandem Health, commented on the partnership: "What excites me about this partnership is that Compucare approached it the way we do - carefully, with governance front of mind. For healthcare organisations, that means AI documentation that's not just capable, but certified and enterprise-ready from day one." Over recent months, Streets Heaver undertook a detailed review of the Ambient AI market, assessing a range of solutions against the requirements of private healthcare organisations and NHS Private Patient Units. While functionality was an important consideration, governance, regulatory standards and long-term strategic fit were equally critical. Tandem stood out for three key reasons: * MDR Class IIa certification for its Scribe & Coding Assistant * An externally audited development and quality process * A commitment to deep platform integration rather than operating as a disconnected third-party application Andy Robinson, Head of Technology at Streets Heaver, explained: "The integration Streets Heaver is delivering isn't a bolt-on. Clinicians will launch Tandem directly from Compucare, patient and appointment context will flow through automatically, and approved notes and correspondence will return directly to the patient record. What made Tandem the right partner was the combination of MDR Class IIa certification, an externally audited build process and a genuine commitment to deep integration. They build the way Streets Heaver build: modular, deliberate and enterprise-first. Complementing this is its native AI, NIVA, already integrated into its products, helping to extend its AI vision while maintaining a strong focus on safety and transparency." Why Ambient AI matters now. The partnership reflects a broader shift in what clinicians expect from healthcare technology. Today's clinicians are accustomed to intuitive, consumer-grade experiences in their everyday lives. Increasingly, they expect the same simplicity and responsiveness from the systems they use at work. At the same time, healthcare organisations face growing documentation requirements, increasing administrative pressure and rising volumes of clinical data. The challenge is not simply digitising paper processes. The challenge is helping clinicians access the right information, at the right time, without introducing additional complexity into their workflows. Streets Heaver's Customer Success Manager, Mark Wilkinson, believes the integration addresses one of the biggest frustrations clinicians face during consultations: balancing documentation with patient interaction. "Tandem will be a big step forward for clinicians. Many are already using AI-powered dictation tools like Tandem to capture their assessment notes, but integrating that capability directly into Clinician Pro is the missing piece. Clinicians use dictation because they want to focus their full attention on the patient during consultations. Having to stop and write notes throughout the conversation is distracting, whereas this integration allows documentation to happen seamlessly without interrupting patient care." At Streets Heaver, this philosophy has shaped the development of Compucare Clinician Pro, where usability, workflow alignment and information relevance are central design priorities. As Candy Mussett, Head of Operations at Streets Heaver, explains: "Healthcare technology should feel like a natural extension of clinical practice. Clinicians need systems that are intuitive, reliable and designed around the way they actually work." Stuart Hymers, Head of Commercials, adds: "Technology works best when it's designed with clinicians, not for clinicians. The closer we align software to real-world clinical workflows, the more value it delivers." Ambient AI represents an important step in that journey. By reducing the time spent on documentation and administration, clinicians can focus more of their attention on patient interactions and clinical decision-making. Building on the Vision for AI at Streets Heaver. This partnership complements Streets Heaver's wider AI roadmap and ongoing investment in innovation across the Compucare platform. Alongside Tandem's Ambient AI capabilities, Streets Heaver continues to develop NIVA, its native AI platform designed to deliver intelligent assistance across healthcare workflows. The company's vision is clear: AI should support clinicians and operational teams by reducing complexity, surfacing relevant information and improving efficiency, while maintaining transparency, governance and human oversight. As healthcare organisations continue to generate increasing volumes of clinical and operational data, the opportunity for AI extends beyond documentation alone. Future innovation will focus on helping users access meaningful insights faster, identify trends more effectively and make better-informed decisions without increasing workload. The objective is not to replace clinical judgement. It is to support it. Looking ahead. Hosted Compucare customers will be among the first to benefit from the deep integration capabilities being introduced through the partnership. Over the coming weeks, Streets Heaver and Tandem Health will begin engaging with customers to demonstrate the technology, discuss implementation options and explore how Ambient AI can support different clinical environments. This partnership represents another step towards a future where healthcare technology becomes increasingly intuitive, intelligent and aligned to the realities of clinical practice. Book a demonstration. Book a personalised demonstration to discover how Compucare, Tandem Health and NIVA are helping healthcare organisations reduce administrative burden, improve clinician productivity and deliver more efficient patient care.